ARAVIVE, INC EBITDA Margin

EBITDA Margin of ARAV for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBITDA Margin growth rates and interactive chart.

Highlights and Quick Summary

  • EBITDA Margin for the quarter ending September 30, 2023 was -315.38% (a -67.51% decrease compared to previous quarter)
  • Year-over-year quarterly EBITDA Margin decreased by -76.33%
  • Annual EBITDA Margin for 2022 was -765.58% (a 43.6% increase from previous year)
  • Annual EBITDA Margin for 2021 was -533.12% (a 30.8% increase from previous year)
  • Annual EBITDA Margin for 2020 was -407.58% (a -8.95% decrease from previous year)
  • Twelve month EBITDA Margin ending September 30, 2023 was -834.84% (a 16.25% increase compared to previous quarter)
  • Twelve month trailing EBITDA Margin increased by 9.05% year-over-year
Trailing EBITDA Margin for the last four month:
30 Sep '23 30 Jun '23 31 Mar '23 31 Dec '22
-834.84% -718.13% -764.19% -765.58%
Visit stockrow.com/ARAV for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBITDA Margin of ARAVIVE, INC

Most recent EBITDA Marginof ARAV including historical data for past 10 years.

Interactive Chart of EBITDA Margin of ARAVIVE, INC

ARAVIVE, INC EBITDA Margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 -315.38% -970.57% -1186.99% – –
2022 -1332.56% -329.44% -1189.23% -1353.11% -765.58%
2021 -1363.25% -469.36% -188.92% -3034.38% -533.12%
2020 -167.25% 0.0% 0.0% 0.0% -407.58%
2019 0.0% 0.0% -122.86% -330.37% -447.63%
2018 0.0% 0.0% 0.0% 0.0% -2322.32%
2017 0.0% 0.0% 0.0% 0.0% -210.43%
2016 0.0% 0.0% 0.0% 0.0% 0.0%
2015 0.0% 0.0% 0.0% 0.0% 0.0%
2014 0.0% 0.0% 0.0% 0.0% 0.0%
2013 0.0% 0.0% 0.0% 0.0% 0.0%
2012 – – – – 0.0%

Business Profile of ARAVIVE, INC

Sector: Healthcare
Industry: Biotechnology
© stockrow.com